{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T05:32:45Z","timestamp":1793338365711,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,26]],"date-time":"2024-07-26T00:00:00Z","timestamp":1721952000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["lipidjournal.com","clinicalkey.fr","clinicalkey.jp","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Clinical Lipidology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/j.jacl.2024.07.003","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T12:03:11Z","timestamp":1721649791000},"page":"e720-e728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Race\/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2644-6807","authenticated-orcid":false,"given":"Marianna","family":"Pavlyha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-8722-3437","authenticated-orcid":false,"given":"Yihao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1136-8196","authenticated-orcid":false,"given":"Sarah","family":"Crook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0450-9387","authenticated-orcid":false,"given":"Brett R.","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6746-4569","authenticated-orcid":false,"given":"Gissette","family":"Reyes-Soffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"1","key":"10.1016\/j.jacl.2024.07.003_bib0001","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): A genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American heart association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"18","key":"10.1016\/j.jacl.2024.07.003_bib0002","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2024.03.367","article-title":"Association of lipoprotein(a) levels with myocardial infarction in patients with low-attenuation plaque","volume":"83","author":"Yu","year":"2024","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.003_bib0003","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1001\/jamacardio.2023.5605","article-title":"Lipoprotein(a), C-reactive protein, and cardiovascular risk in primary and secondary prevention populations","volume":"9","author":"Small","year":"2024","journal-title":"JAMA Cardiol"},{"issue":"8","key":"10.1016\/j.jacl.2024.07.003_bib0004","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"issue":"6","key":"10.1016\/j.jacl.2024.07.003_bib0005","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1016\/j.jacc.2016.11.042","article-title":"A test in context: lipoprotein(a): diagnosis, prognosis, controversies, and emerging therapies","volume":"69","author":"Tsimikas","year":"2017","journal-title":"J Am Coll Cardiol"},{"issue":"1","key":"10.1016\/j.jacl.2024.07.003_bib0006","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (Lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease: new insights from a large national biobank","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"3","key":"10.1016\/j.jacl.2024.07.003_bib0007","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000319065","article-title":"Increased stroke risk and lipoprotein(a) in a multiethnic community: the Northern Manhattan Stroke Study","volume":"30","author":"Boden-Albala","year":"2010","journal-title":"Cerebrovasc Dis"},{"issue":"2","key":"10.1016\/j.jacl.2024.07.003_bib0008","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1161\/CIRCULATIONAHA.111.045120","article-title":"Associations between lipoprotein(a) levels and cardiovascular outcomes in black and white subjects: the atherosclerosis risk in communities (ARIC) study","volume":"125","author":"Virani","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.07.003_bib0009","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.atherosclerosis.2022.10.004","article-title":"Relationship of low-density lipoprotein-cholesterol and lipoprotein(a) to cardiovascular risk: the multi-ethnic study of atherosclerosis (MESA)","volume":"363","author":"Rikhi","year":"2022","journal-title":"Atherosclerosis"},{"issue":"24","key":"10.1016\/j.jacl.2024.07.003_bib0010","doi-asserted-by":"crossref","first-page":"e454","DOI":"10.1161\/CIR.0000000000000936","article-title":"Call to action: structural racism as a fundamental driver of health disparities: a presidential advisory from the American heart association","volume":"142","author":"Churchwell","year":"2020","journal-title":"Circulation"},{"issue":"8","key":"10.1016\/j.jacl.2024.07.003_bib0011","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian cardiovascular society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"issue":"39","key":"10.1016\/j.jacl.2024.07.003_bib0012","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"issue":"24","key":"10.1016\/j.jacl.2024.07.003_bib0013","doi-asserted-by":"crossref","first-page":"3168","DOI":"10.1016\/j.jacc.2018.11.002","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: executive summary: a report of the American college of cardiology\/American heart association task force on clinical practice guidelines","volume":"73","author":"Grundy","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/j.jacl.2024.07.003_bib0014","doi-asserted-by":"crossref","DOI":"10.1016\/j.jacl.2024.03.001","article-title":"A focused update to the 2019 NLA scientific statement on use of lipoprotein(a) in clinical practice","author":"Koschinsky","year":"2024","journal-title":"J Clin Lipidol"},{"issue":"18","key":"10.1016\/j.jacl.2024.07.003_bib0015","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.123.031255","article-title":"Lipoprotein(a) testing trends in a large academic health system in the United States","volume":"12","author":"Bhatia","year":"2023","journal-title":"J Am Heart Assoc"},{"issue":"11","key":"10.1016\/j.jacl.2024.07.003_bib0016","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1161\/ATVBAHA.116.308011","article-title":"Prevalence of elevated Lp(a) mass levels and patient thresholds in 532 359 patients in the United States","volume":"36","author":"Varvel","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"issue":"4","key":"10.1016\/j.jacl.2024.07.003_bib0017","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1177\/0003319719826461","article-title":"Lipoprotein(a) in patients undergoing transcatheter aortic valve replacement","volume":"70","author":"Ma","year":"2019","journal-title":"Angiology"},{"issue":"8","key":"10.1016\/j.jacl.2024.07.003_bib0018","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1023\/A:1011240019516","article-title":"Socioeconomic status and breast cancer incidence in California for different race\/ethnic groups","volume":"12","author":"Yost","year":"2001","journal-title":"Cancer Causes Control"},{"key":"10.1016\/j.jacl.2024.07.003_bib0019","first-page":"277","article-title":"Understanding and enhancing the U.S. department of housing and urban development's ZIP code crosswalk files","volume":"20","author":"Wilson","year":"2018","journal-title":"Cityscape: A J Policy Dev Res"},{"key":"10.1016\/j.jacl.2024.07.003_bib0020","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.atherosclerosis.2023.01.014","article-title":"Trends and consequences of lipoprotein(a) testing: Cross-sectional and longitudinal health insurance claims database analyses","volume":"367","author":"Sturzebecher","year":"2023","journal-title":"Atherosclerosis"},{"issue":"11","key":"10.1016\/j.jacl.2024.07.003_bib0021","first-page":"1090","article-title":"Trends in lipid screening among adults in an integrated health care delivery system, 2009-2015","volume":"24","author":"Grant","year":"2018","journal-title":"J Manag Care Spec Pharm"},{"issue":"3","key":"10.1016\/j.jacl.2024.07.003_bib0022","first-page":"1","article-title":"Clinical utility of lipoprotein(a) and LPA genetic risk score in risk prediction of incident atherosclerotic cardiovascular disease","volume":"6","author":"Trinder","year":"2020","journal-title":"JAMA Cardiol"},{"issue":"7","key":"10.1016\/j.jacl.2024.07.003_bib0023","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1001\/jamacardio.2019.1581","article-title":"Genetic variation in LPA, calcific aortic valve stenosis in patients undergoing cardiac surgery, and familial risk of aortic valve microcalcification","volume":"4","author":"Perrot","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/j.jacl.2024.07.003_bib0024","article-title":"Lipoprotein(a): An important piece of the ASCVD risk factor puzzle across diverse populations","volume":"38","author":"Ciffone","year":"2024","journal-title":"Am Heart J Plus"},{"issue":"22","key":"10.1016\/j.jacl.2024.07.003_bib0025","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American heart association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/j.jacl.2024.07.003_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100053","article-title":"Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements","volume":"62","author":"Yeang","year":"2021","journal-title":"J Lipid Res"},{"issue":"18","key":"10.1016\/j.jacl.2024.07.003_bib0027","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.014711","article-title":"Risks of incident cardiovascular disease associated with concomitant elevations in lipoprotein(a) and low-density lipoprotein cholesterol-the Framingham heart study","volume":"9","author":"Afshar","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/j.jacl.2024.07.003_bib0028","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.amjcard.2021.05.018","article-title":"Lipoprotein(a) testing patterns in a large health system","volume":"153","author":"Kelsey","year":"2021","journal-title":"Am J Cardiol"},{"issue":"12","key":"10.1016\/j.jacl.2024.07.003_bib0029","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) Levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Pare","year":"2019","journal-title":"Circulation"},{"issue":"5","key":"10.1016\/j.jacl.2024.07.003_bib0030","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1161\/CIRCRESAHA.121.319811","article-title":"Social determinants of cardiovascular disease","volume":"130","author":"Powell-Wiley","year":"2022","journal-title":"Circ Res"},{"key":"10.1016\/j.jacl.2024.07.003_bib0031","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1093\/oxfordjournals.epirev.a036030","article-title":"The measurement of social class in epidemiology","volume":"10","author":"Liberatos","year":"1988","journal-title":"Epidemiol Rev"},{"key":"10.1016\/j.jacl.2024.07.003_bib0032","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3109\/03009748909101475","article-title":"Potential influences of ketoprofen on human healthy and osteoarthritic cartilage in vitro","volume":"83","author":"Huber-Bruning","year":"1989","journal-title":"Scand J Rheumatol Suppl"},{"issue":"6","key":"10.1016\/j.jacl.2024.07.003_bib0033","doi-asserted-by":"crossref","first-page":"988","DOI":"10.1016\/j.ahj.2009.03.019","article-title":"Adding socioeconomic status to Framingham scoring to reduce disparities in coronary risk assessment","volume":"157","author":"Fiscella","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/j.jacl.2024.07.003_bib0034","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.atherosclerosis.2016.11.010","article-title":"Ideal cardiovascular health influences cardiovascular disease risk associated with high lipoprotein(a) levels and genotype: The EPIC-Norfolk prospective population study","volume":"256","author":"Perrot","year":"2017","journal-title":"Atherosclerosis"},{"issue":"27","key":"10.1016\/j.jacl.2024.07.003_bib0035","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1093\/eurheartj\/ehy334","article-title":"Cardiovascular disease risk associated with elevated lipoprotein(a) attenuates at low low-density lipoprotein cholesterol levels in a primary prevention setting","volume":"39","author":"Verbeek","year":"2018","journal-title":"Eur Heart J"},{"issue":"11","key":"10.1016\/j.jacl.2024.07.003_bib0036","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1016\/j.metabol.2016.08.007","article-title":"Effect of extended-release niacin on plasma lipoprotein(a) levels: A systematic review and meta-analysis of randomized placebo-controlled trials","volume":"65","author":"Sahebkar","year":"2016","journal-title":"Metabolism"},{"issue":"10057","key":"10.1016\/j.jacl.2024.07.003_bib0037","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"}],"container-title":["Journal of Clinical Lipidology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002113?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1933287424002113?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T06:33:07Z","timestamp":1732602787000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1933287424002113"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S1933287424002113"],"URL":"https:\/\/doi.org\/10.1016\/j.jacl.2024.07.003","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2024.05.14.24307362","asserted-by":"object"}]},"ISSN":["1933-2874"],"issn-type":[{"value":"1933-2874","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Race\/ethnicity and socioeconomic status affect the assessment of lipoprotein(a) levels in clinical practice","name":"articletitle","label":"Article Title"},{"value":"Journal of Clinical Lipidology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jacl.2024.07.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 National Lipid Association. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}